Beta 1,4-N-acetylgalactosaminyltransferases from C. jejuni

Details Beta 1,4-N-acetylgalactosaminyltransferases from C. jejuni Beta 1,4-N-acetylgalactosaminyltransferases from C. jejuni

2008-06-10

2008-06-10

Swope, Sheridan (Department: 1652)

Chemistry: molecular biology and microbiology

Enzyme , proenzyme; compositions thereof; process for...

Transferase other than ribonuclease

C435S071100, C435S070100, C530S412000

Reexamination Certificate

active

07384771

ABSTRACT:
This invention provides prokaryotic β1,4-N-acetylgucosaminyl (GalNAc) transferases involved in synthesis of lipooligosaccharide (LOS). The β1,4-GalNAc transferases can be obtained from, for example,Campylobacterspecies, includingC. jejuni. In additional embodiments, the invention provides nucleic acids that encode the β1,4-GalNAc transferases, as well as expression vectors and host cells for expressing the β1,4-GalNAc transferases.

REFERENCES:
patent: 5352670 (1994-10-01), Venot et al.
patent: 5374541 (1994-12-01), Wong et al.
patent: 5545553 (1996-08-01), Gotschlich
patent: WO 92/16640 (1992-10-01), None
patent: WO 96/32491 (1996-10-01), None
patent: WO 99/49051 (1999-09-01), None
patent: WO 00/46379 (2000-08-01), None
Galye et al, Identification of regions in interleukin-1 alpha important for activity. J Biol Chem. Oct. 15,1993;268(29):22105-11.
Whisstock et al, Prediction of protein function from protein sequence and structure. Q Rev Biophys. Aug. 2003; 36(3):307-40. Review.
Parkhill et al, The genome sequence of the food-borne pathogenCampylobacter jejunireveals hypervariable sequences. Nature. Feb. 10, 2000;403(6770):665-8.
PIR—80 database Accession No. B81319 Mar. 31, 2000 Parkhill et al, Alignment with SEQ ID No. 19.
Guerry et al, Sialylation of lipooligosaccharide cores affects immunogenicity and serum resistance ofCampylobacter jejuni. Infect Immun. Dec. 2000;68(12):6656-62.
GenEmbl database Accession No. AF257460 Dec. 3, 2000 Guerry et al. Alignment with SEQ ID No. 19.
Ausubel et al, 1987 Chapter 16 Protein Expression. In: Current protocols in molecular biology. John Wiley & Sons, Inc. New York, NY.
In house USPTO Blast alignment of NCBI Accession No. Q9PNF1, Parkhill et al, 2000, with NCBI Accession No. AAG37023, Guerry et al, 2000.
Blixt et al, Chemoenzymatic synthesis of 2-azidoethyl-ganglio-oligosaccharides GD3, GT3, GM2, GD2, GT2, GM1, and GD1a, Carbohydr Res. Sep. 5, 2005;340(12):1963-72.
Birkle et al, Role of tumor-associated gangliosides in cancer progression. Biochimie. Mar.-Apr. 2003;85(3-4):455-63. Review.
Livingston et al, Ganglioside vaccines with emphasis on GM2. Semin Oncol. Dec. 1998;25(6):636-45. Review.
Aspinall et al., “Lipopolysaccharides ofCampylobacter jejuniSerotype O:19: Structures of Core Oligosaccharide Regions from the Serostrain and Two Bacterial Isolates from Patients with the Gullain-Barré Syndrome” Biochemistry, 33: 241-249 (1994b).
Aspinall et al., “Lipopolysaccharides ofCampylobacter jejuniSerotype O:19: Antigen Chains from the Serostrain and Two Bacterial Isolates from Patients with the Guillian-Barré Syndrome” Biochemistry, 33:250-255 (1994c).
Aspinall, et al. “Chemical Structures of the Core Regions ofCampylobacter jejuniSerotypes 0:1, 0:4,0:23, and 0:36 Lipopolysaccharides,” European Journal of Biochemistry, vol. 213, No. 3, pp. 1017-1027, (May 1993).
Aspinall, et al. “Lipopolysaccharides fromCampylobacter jejuniAssociated with Guillain-Barreé Syndrome Patients Mimic Human Gangliosides in Structure,” Infection and Immunity, vol. 62, No. 5, pp. 2122-2125, (May 1994).
Belunis et al., “Biosynthesis of Endotoxin” J. Biol. Chem., 267:9988-9997 (1992).
Gaudino et al., “A Novel and Efficient Synthesis of Neolacto Series Gangliosides 3′-nLM1 and 6′-nLM1” J. Am. Chem. Soc., 116:1149-1150 (1994).
Gilbert et al., “Cloning of the Lipooligosaccharide α-2,3-Sialyltransferase from the Bacterial PathogensNeisseria MeningitidisandNeisseria Gonorrhoeae”, Journal of Biological Chemistry, vol. 271, No. 45, pp. 28271-28276, The American Society for Biochemistry and Molecular Biology, Inc., USA, (Nov. 8, 1996).
Gilbert, et al., “Biosynthesis of Ganglioside Mimics inCampylobacter jejuniOH4384,” The Journal of Biolofical Chemistry, vol. 275, No. 6, pp. 3896-3906, The American Society for Biochemistry and Molecular Biology, Inc., USA, (Feb. 11, 2000).
Ito et al., “Synthesis of Bioactive Sialosides” Pure Appl. Chem., 65: 753 (1993).
Kuroki, “Campylobacter jejuniStrains from Patients with Guillain-Barré Syndrome Belong Mostly to Penner Serogroup 19 Contain β-N-Acetylglucosamine Residues” Ann. Neurol., 33: 243-247 (1993).
Parkhill, et al. “The Genome Sequence of the Food-Borne PathogenCampylobacter jejuniReveals Hypervariable Sequences,” Nature, vol. 403, pp. 665-668, (Feb. 10, 2000).
Penner, et al., “Diversity of Lipopolysaccharide Structures inCampylobacter jejuni,” The Journal of Infectious Diseases, vol. 176, No. 2, pp. S135-S138, (Dec. 1997).
Prendergast, et al., “Lipopolysaccharides formCampylobacter jejuniO:41 Strains Associated with Guillain-Barré Syndrome Exhibit Mimicry of GM1 Ganglioside,” Infection and Immunity, vol. 66, No. 8, pp. 3649-3677, (Aug. 1998).
Preston, et al., “The Lipooligosaccharides of Pathogenic Gram-Negative Bacteria,” Critical Reviews in Microbiology, vol. 22. No. 3, pp. 139-180, (1996).
Sabesan et al., “Combined Chemical and Enzymatic Synthesis of Sialyloligosaccharides and Characterization by 500-MHz 1H and C NMR Spectroscopy” J. Am. Chem. Soc., 108:2068-2080 (1986).
Salloway, et al., “Miller-Fisher Syndrome Associated withCampylobacter jejuniBearing Lipopolysaccharide Molecules that Mimie Human Ganglioside GD3,” Infection and Immunity, vol. 64, No. 8, pp. 2945-2949, (Aug. 1996).
Wakarchuk et al., “Functional Relationships of the Genetic Locus Encoding the Glycosyltransferase Enzymes Involved in Expression of the Lacto-N-neotetraose Terminal Lipopolysaccharide Structure inNeisseria meningitidis” J. Biol. Chem., 271: 19166-19173 (1996).
Wood, et al., “Cloning, Mutation and Distribution of a Putative Lipopolysaccharide Biosynthesis Locus inCampylobacter jejuni,” Microbiology, vol. 145, No. 2, pp. 379-388, (Feb. 1999).
Tomb, et al., The complete genome sequence of the gastric pathogenHelicobacter pylori, Swiss-ProtAcc#A64547. Alignment with SEQ ID No. 17.
Wakarchuk et al., “Functional Relationships of the Genetic Locus Encoding the Glycosyltransferase Enzymes Involved in Expression of the Lacto-N-neotetraose Terminal Lipopolysaccharide Structure inNeisseria meningitidis” J. Biol. Chem., 271: 19166-19173 ( 1996).
Wood, et al., “Cloning, Mutation and Distribution of a Putative Lipopolysaccharide Biosynthesis Locus inCampylobacter jejuni,” Microbiology, vol. 145, No. 2, pp. 379-388, (Feb. 1999).
http://web.archive.org/web/web/*/http://www.sanger.ac.uk/Projects/C—jejuni/ Search Results for Jan. 1, 1996-Apr. 7, 2004.

Affiliated with

Also associated with

Rating

Beta 1,4-N-acetylgalactosaminyltransferases from C. jejuni does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Beta 1,4-N-acetylgalactosaminyltransferases from C. jejuni, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Beta 1,4-N-acetylgalactosaminyltransferases from C. jejuni will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2803444